Icad Ownership

ICAD Stock  USD 1.73  0.04  2.26%   
icad inc has a total of 26.35 Million outstanding shares. Icad retains 5.63 (percent) of its outstanding shares held by insiders and 27.15 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2009-03-31
Previous Quarter
26 M
Current Value
26 M
Avarage Shares Outstanding
16.8 M
Quarterly Volatility
5.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Icad in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Icad, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
At present, Icad's Dividend Yield is projected to slightly decrease based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 26.9 M, whereas Net Loss is forecasted to decline to (12.9 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Icad Stock Ownership Analysis

About 27.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. icad inc recorded a loss per share of 0.2. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 16th of August 2012. iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people. To learn more about icad inc call Dana Brown at 603 882 5200 or check out https://www.icadmed.com.
Besides selling stocks to institutional investors, Icad also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Icad's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Icad's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Icad Quarterly Liabilities And Stockholders Equity

37.11 Million

About 6.0% of icad inc are currently held by insiders. Unlike Icad's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Icad's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Icad's insider trades

Icad Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Icad is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading icad inc backward and forwards among themselves. Icad's institutional investor refers to the entity that pools money to purchase Icad's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Citadel Advisors Llc2024-09-30
140.6 K
Essex, Llc2024-09-30
138 K
Morgan Stanley - Brokerage Accounts2024-06-30
102.4 K
Bridgeway Capital Management, Llc2024-09-30
74.6 K
Salem Investment Counselors Inc2024-06-30
73.9 K
State Street Corp2024-06-30
72.1 K
Susquehanna International Group, Llp2024-06-30
71.1 K
Wells Fargo & Co2024-06-30
59.7 K
Northern Trust Corp2024-09-30
54.5 K
Vanguard Group Inc2024-09-30
1.1 M
Arnhold & S. Bleichroeder Advisers, Llc2024-09-30
675.2 K
Note, although Icad's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

icad inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Icad insiders, such as employees or executives, is commonly permitted as long as it does not rely on Icad's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Icad insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Icad Outstanding Bonds

Icad issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. icad inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icad bonds can be classified according to their maturity, which is the date when icad inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.20)
Revenue Per Share
0.718
Quarterly Revenue Growth
0.206
Return On Assets
(0.08)
Return On Equity
(0.15)
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.